Opportunistic diseases diminish the clinical benefit of immediate co-infected antiretroviral adults with therapy low CD4 in HIV-tuberculosis R cell counts

William Worodria, Victor Ssempijja, Coleen Hanrahan, Richard Ssegonja, Abdallah Muhofwa, Doreen Mazapkwe, Harriet Mayanja-Kizza, Steven J. Reynolds, Robert Colebunders, Yukari C. Manabe

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Opportunistic diseases diminish the clinical benefit of immediate co-infected antiretroviral adults with therapy low CD4 in HIV-tuberculosis R cell counts'. Together they form a unique fingerprint.

Medicine & Life Sciences